(Q33545615)

27 July 2017

1 reference

title

National guidelines needed to manage rhinitis and prevent complications (English)

1 reference

27 July 2017

Rachelefsky GS

1

1 reference

27 July 2017

publication date

1 March 1999

1 reference

Annals of Allergy, Asthma & Immunology

27 July 2017

published in

1 reference

27 July 2017

volume

82

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

296-305

1 reference

Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Asthma and indoor exposure to allergens.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The role of nasal airway obstruction in sinus disease and facial development

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Is allergic rhinitis more frequent in young adults with extreme shyness? A preliminary survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Occupational injuries and medication use.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

An economic evaluation of asthma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Seasonal trends in US asthma hospitalizations and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Asthma and allergic rhinitis in Swedish conscripts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Prevalence of asthma in Melbourne schoolchildren: changes over 26 years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The prevalence of asthma and respiratory symptoms among young adults: is it increasing in Australia?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Association of asthma with serum IgE levels and skin-test reactivity to allergens

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The interrelationship among allergy, airways responsiveness, and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Associations between respiratory symptoms, bronchial response to methacholine, and atopy in two age groups of schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Inhalation tests of bronchial hypersensitivity in pollen asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The role of ragweed pollen in autumnal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Epidemiology of emergency room asthma in northern California: association with IgE antibody to ryegrass pollen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Reduction of bronchial hyperreactivity during prolonged allergen avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Natural history of childhood asthma. 20-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Allergic and nonallergic rhinitis: Their characterization with attention to the meaning of nasal eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Asthma and allergic rhinitis in the same patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Prevalence and impact of multiple childhood chronic illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. IV. Natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Asthma from birth to age 23: incidence and relation to prior and concurrent atopic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Comparison of responses to pollen extract in subjects with allergic asthma and nonasthmatic subjects with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Different prevalence and degree of nonspecific bronchial hyperreactivity between seasonal and perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The presence of airway reactivity before the development of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Inhalation challenge with ragweed pollen in ragweed-sensitive asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Changes in bronchial responsiveness following nasal provocation with allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Airway cooling in asthmatic and nonasthmatic subjects during nasal and oral breathing

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Sinus disease in children with respiratory allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Allergy in patients with acute maxillary sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Natural immunity to dust mites in patients with chronic rhinosinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Middle meatus anstrostomy: patency rates and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Maxillary sinusitis and bronchial asthma: Correlation of roentgenograms, cultures, and thermograms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Otitis media and eustachian tube dysfunction: connection to allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Inflammatory mediators in chronic otitis media with effusion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Nasal polyps and sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Nasal polyps in asthma and rhinitis. A review of 6,037 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Immunologic studies in allergen-induced late-phase asthmatic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Antiallergic activity of H1-receptor antagonists assessed by nasal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Protective effect of loratadine on late phase reaction induced by conjunctival provocation test

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Duration of effect of loratadine and terfenadine administered once a day for one week on cutaneous and inhaled reactivity to histamine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Effect of a non-sedative antihistaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover-trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Responses to ragweed-pollen nasal challenge before and after immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Ragweed immunotherapy in adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Changes in challenge tests following hyposensitization with mite extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with astham

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

The control of allergens of dust mites and domestic pets: a position paper

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962612-9

7 January 2021

10.1016/S1081-1206(10)62612-9

Identifiers

DOI

1 reference

27 July 2017

1 reference